Transcat, Inc. (NASDAQ:TRNS - Free Report) - Analysts at Northland Capmk reduced their Q3 2025 earnings per share estimates for shares of Transcat in a report released on Monday, December 16th. Northland Capmk analyst E. Jackson now anticipates that the scientific and technical instruments company will earn $0.33 per share for the quarter, down from their previous estimate of $0.41. The consensus estimate for Transcat's current full-year earnings is $1.76 per share. Northland Capmk also issued estimates for Transcat's Q4 2025 earnings at $0.51 EPS and FY2025 earnings at $1.68 EPS.
Several other research firms have also commented on TRNS. Craig Hallum upped their target price on Transcat from $113.00 to $125.00 and gave the company a "buy" rating in a report on Thursday, December 12th. StockNews.com downgraded Transcat from a "hold" rating to a "sell" rating in a research note on Tuesday, October 29th. HC Wainwright reiterated a "buy" rating and issued a $156.00 target price on shares of Transcat in a research note on Tuesday, October 29th. Northland Securities reduced their price target on shares of Transcat from $130.00 to $110.00 and set a "market perform" rating for the company in a report on Wednesday, October 30th. Finally, Oppenheimer reaffirmed an "outperform" rating and issued a $130.00 price objective (down previously from $155.00) on shares of Transcat in a report on Wednesday, October 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $130.25.
Read Our Latest Stock Analysis on Transcat
Transcat Stock Up 0.3 %
TRNS opened at $109.50 on Wednesday. The company's 50-day moving average price is $110.94 and its 200 day moving average price is $119.06. Transcat has a fifty-two week low of $94.29 and a fifty-two week high of $147.12. The firm has a market cap of $1.01 billion, a price-to-earnings ratio of 55.30 and a beta of 0.70.
Transcat (NASDAQ:TRNS - Get Free Report) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share for the quarter, missing analysts' consensus estimates of $0.47 by ($0.12). Transcat had a return on equity of 7.36% and a net margin of 6.63%. The business had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. During the same period last year, the company posted $0.41 earnings per share. The firm's revenue for the quarter was up 8.0% on a year-over-year basis.
Institutional Investors Weigh In On Transcat
Several institutional investors have recently bought and sold shares of TRNS. DekaBank Deutsche Girozentrale acquired a new position in Transcat during the 2nd quarter valued at about $40,000. nVerses Capital LLC bought a new position in shares of Transcat in the third quarter valued at approximately $60,000. First Horizon Advisors Inc. boosted its holdings in shares of Transcat by 26.4% in the second quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company's stock valued at $72,000 after acquiring an additional 125 shares in the last quarter. Fifth Third Bancorp increased its stake in shares of Transcat by 95.8% during the second quarter. Fifth Third Bancorp now owns 656 shares of the scientific and technical instruments company's stock valued at $79,000 after acquiring an additional 321 shares during the period. Finally, Quest Partners LLC bought a new stake in Transcat during the second quarter worth approximately $109,000. Institutional investors and hedge funds own 98.34% of the company's stock.
Transcat Company Profile
(
Get Free Report)
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
See Also
Before you consider Transcat, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Transcat wasn't on the list.
While Transcat currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
